Product Information
AMPHETAMINE ER 18.8 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $16.2013 per EA under NDC 00480332065. Its NADAC has been published 30 times since Jan 28, 2026.
FDA first approved this application on Jun 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
18.8 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480332065
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209253FDA Approved
6/22/2023
TE Code
AB
On Market Since
12/8/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 18.8 MG ODT has been published 30 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2013 per EA |
|---|---|
| All-time high | $16.5172 (Feb 11, 2026) |
| All-time low | $16.2013 (Aug 19, 2026) |
| 52-week high | $16.5172 |
| 52-week low | $16.2013 |
| Median price | $16.3536 |
| Average price | $16.3741 |
| Largest weekly change | -0.8% (Aug 19, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 18.8 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 18.8 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $16.2013 per EA (NDC 00480332065), effective Aug 19, 2026.
How has the price of AMPHETAMINE ER 18.8 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 18.8 MG ODT has held within roughly two percent of its current level. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 18.8 MG ODT?
Since Jan 28, 2026, the NADAC for AMPHETAMINE ER 18.8 MG ODT has ranged from a low of $16.2013 (Aug 19, 2026) to a high of $16.5172 (Feb 11, 2026), with a median of $16.3536 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 18.8 MG ODT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMPHETAMINE ER 18.8 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures AMPHETAMINE ER 18.8 MG ODT?
AMPHETAMINE ER 18.8 MG ODT (NDC 00480332065) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.